Markos Leggas

15PUBLICATIONS
70CO-AUTHORS
NanomedicinePredictive and prognostic markersPharmacogenomicsInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 23, 2026
The nucleoside analog kamuvudine-9 shows protective and therapeutic efficacy in a mouse model of multiple sclerosis.

|Sep 12, 2026
Bridging tumor growth dynamics and survival in preclinical oncology drug development - a Tumor Growth Inhibition and Time-to-Event (TGI-TTE) modeling framework.

|Aug 11, 2026
Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.

|Jun 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

|Jul 03, 2025
Age-adjusted dosing of fludarabine for lymphodepletion in CAR T-cell therapy: a clinical trial simulation study.

John C Panetta, Aimee C Talleur, Swati Naik

|Jun 27, 2025
Preclinical Pharmacokinetic Evaluation of Mithramycin and Mithramycin SA Tryptophan-Conjugated Analog.

Kumar Kulldeep Niloy, Jamie Horn, Nazmul H Bhuiyan

Pageof 3

Frequent Collaborators

3 joint publications

Khaled A Shaaban

2 joint publications

Jamie Horn

1 joint publications

J R Rivas

1 joint publications

Y Liu